Table 1.
Composition of Crystalloid Solutions
Fluid | Sodium | Potassium | Calcium | Magnesium | Chloride | Acetate | Gluconate | Malate | Lactate | Osmolarity |
---|---|---|---|---|---|---|---|---|---|---|
Plasma | 135–145 | 4.5–5.0 | 2.2–2.6 | 0.8–1.0 | 94–111 | 0.02–0.2 | 1–2 | 275–295 | ||
Plasma-Lyte A | 140 | 5.0 | 3.0 | 98 | 27 | 23 | 294 | |||
Normosol-R | 140 | 5.0 | 3.0 | 98 | 27 | 23 | 295 | |||
Isolyte S | 141 | 5.0 | 3.0 | 98 | 27 | 23 | 295 | |||
Ringer’s acetate | 145 | 4.0 | 2.5 | 1.0 | 127 | 24 | 5 | 309 | ||
Lactated Ringer’s | 130 | 4.0 | 2.7 | 109 | 28 | 273 | ||||
Hartmann’s solution | 131 | 5.4 | 1.8 | 112 | 28 | 280 | ||||
0.9% sodium chloride | 154 | 154 | 308 |
All values are in mEq/L, except calculated osmolarity, which is in mOsm/L. Plasma-Lyte A is “Multiple Electrolyte Injection, Type 1, USP,” from Baxter Healthcare Corporation; Normosol-R is “Multiple Electrolyte Injection, Type 1, USP,” from Hospira, Inc.; Isolyte S is from B. Braun Medical Inc.; Ringer’s acetate is “Sterofundin ISO, Isotonic Electrolyte Solution,” from B. Braun; lactated Ringer’s is “lactated Ringer’s Injection, USP,” from Baxter Healthcare Corporation; Hartmann’s solution is “Compound Sodium Lactate” from Baxter Healthcare Corporation; and 0.9% saline is “Sodium Chloride Injection, USP,” from Baxter Healthcare Corporation.